1.91
Schlusskurs vom Vortag:
$1.90
Offen:
$1.9
24-Stunden-Volumen:
5,814
Relative Volume:
0.01
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+7.39%
1M Leistung:
-9.71%
6M Leistung:
-54.53%
1J Leistung:
-64.48%
Amplify Seymour Cannabis Etf Stock (CNBS) Company Profile
Firmenname
Amplify Seymour Cannabis Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CNBS mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CNBS
Amplify Seymour Cannabis Etf
|
1.90 | 0 | 0 | 0 | 0 | 0.00 |
![]()
VTI
Vanguard Total Stock Market Etf
|
300.22 | 417.53B | 0 | 0 | 0 | 0.00 |
![]()
SPY
Spdr S P 500 Etf Trust
|
605.41 | 372.57B | 0 | 0 | 0 | 0.00 |
![]()
IVV
Ishares Core S P 500 Etf
|
608.36 | 253.41B | 0 | 0 | 0 | 0.00 |
![]()
VB
Vanguard Small Cap Etf
|
249.52 | 160.59B | 0 | 0 | 0 | 0.00 |
![]()
QQQ
Invesco Qqq Trust Series 1
|
527.63 | 124.43B | 0 | 0 | 0 | 0.00 |
Amplify Seymour Cannabis Etf Aktie (CNBS) Neueste Nachrichten
Cannabis stocks climb on RFK Jr. approval, Senate marijuana-banking hearing - MarketWatch
This Week In Cannabis: Paraguay Nears Adult-Use Sales, JPMorgan Hints At Banking And More On Earnings, NHL, Tyson, STIIIZY, Germany - Benzinga
Are Cannabis ETFs Getting High on Their Own Supply? - Yahoo! Voices
Cannabis ETF Changes: Amplify ETFs Revamp Funds To Boost US Exposure - Benzinga
Major Cannabis ETF Change - New Cannabis Ventures
Amplify ETFs Aligns Global and U.S. Cannabis Exposure Across MJ and CNBS - GlobeNewswire
Cannabis banking bill submission not imminent in the current Congress: Marijuana Moment - Seeking Alpha
Pure Cannabis ETF trims Green Thumb Industries’ position, but it isn’t personal - Green Market Report
The Death of Another Cannabis ETF - New Cannabis Ventures
Amplify ETFs to liquidate cannabis fund MJUS (MJUS:NYSEARCA) - Seeking Alpha
Another Cannabis ETF To Close (NYSEARCA:MJUS) - Seeking Alpha
Jane Street Group LLC Cuts Stock Position in Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) - Defense World
What Stocks Are on the U.S. Marijuana Index? - Investopedia
6 Best-Performing Marijuana ETFs for December 2024 - NerdWallet
Marijuana rescheduling unlikely to lead to cannabis banking reform - MSN
Cannabis stocks gain as Trump picks pro-marijuana Congressman Gaetz for AG post - Seeking Alpha
Weed stocks spike after report on Trump support for marijuana reforms - MSN
Weed stocks spike asTrump backs marijuana reforms (MSOS:NYSEARCA) - Seeking Alpha
Marijuana rescheduling hearing reportedly delayed - MSN
Here’s why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed - MSN
Cannabis stocks rebound amid DEA rescheduling review - MSN
EXCLUSIVE: Emotional Connection With Consumers Is Secret Sauce For Any Brand To Prosper, It's Same With Cannabis, Experts Say - Benzinga
Victory In Commerce Clause Case Could Be The Silver Bullet For Cannabis Industry, Experts Say - Benzinga
7 Best Marijuana ETFs to Consider in 2025 - The Motley Fool
122,438 Shares in Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) Bought by Gateway Wealth Partners LLC - Defense World
Wealth Alliance Makes New Investment in Amplify Seymour Cannabis ETF (NYSEARCA:CNBS) - Defense World
Here’s why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed By Invezz - Investing.com Canada
Marijuana ETFs: The Pros and Cons - Investopedia
Here's Why Tilray Brands Has Become a Much Better Buy Than Canopy Growth - The Motley Fool
CNBC’s Tim Seymour takes ‘glass half full’ view of second quarter cannabis earnings - Green Market Report
Cannabis Investing In The Age Of Legalization With Julian Lin, Tim Seymour And Pablo Zuanic - Seeking Alpha
5 Best Cannabis ETFs to Invest In - Securities.io
How to invest in cannabis stocks - CNN Underscored
Cannabis Investing In The Age Of Legalization - Seeking Alpha
Not DC, But The States: Tim Seymour Discusses How Red States Could Catalyze Cannabis Growth - Markets Insider
Tim Seymour On Running A Cannabis Fund: 'We Focus On Companies Poised For Growth' - Markets Insider
Could Rescheduling Finally Bring Institutional Investment in to Cannabis? - Business of Cannabis -
7 Best Marijuana ETFs to Buy in 2024 - U.S News & World Report Money
Cannabis ETFs Soar On Reports DEA Plans To Reclassify Marijuana - Forbes
Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana - Benzinga
Cannabis stocks gain as DEA pressed for marijuana rescheduling - Seeking Alpha
Cannabis Stocks Shine As Benzinga's Cannabis Capital Conference Unfolds - Benzinga
ETF Themes That Dominated in Q1 2024 - ETF Trends
Is Rescheduling a Certainty for Cannabis? ETFs That Surge - Yahoo Finance
Cannabis ETFs Jump on Imminent Rescheduling News - Yahoo Finance
Understanding Cannabis ETFs’ Wacky Divergence - ETF Trends
Cannabis stocks rebound amid DEA's rescheduling review - Seeking Alpha
10 Best Cannabis Stocks & ETFs to Watch - FinMasters
Cannabis Stocks: Why Tomorrow Might Be Too Late To Invest And How To Pick The Right Stocks - Benzinga
Marijuana ETFs Rise – and Fall – on Regulatory Hopes - ETF Trends
Cannabis Stocks & ETFs: Can the Recent Surge Continue? - 24/7 Wall St.
Finanzdaten der Amplify Seymour Cannabis Etf-Aktie (CNBS)
Es liegen keine Finanzdaten für Amplify Seymour Cannabis Etf (CNBS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):